Introduction: Magnesium sulfate is a calcium antagonist that inhibits bronchial smooth muscle contraction promoting bronchodilation. It is used for the management of acute severe asthma in children; however most of the studies have been performed in adults.
Objective: To evaluate the effectiveness of intravenous magnesium sulfate for the treatment of pediatric patients with acute severe asthma exacerbations.
Population and methods: A clinical, randomized, controlled trial was conducted between March 2006 and March 2011 at Hospital Universitario Austral. Children with acute severe asthma admitted to the emergency department were randomized into two groups. Group A (control group): standard protocol for the initial treatment of acute asthma exacerbation. Group B: treatment protocol with magnesium sulphate for acute severe asthma exacerbation. The primary outcome was the requirement of invasive or non invasive mechanical ventilation support.
Results: One hundred and forty three patients randomized into 2 groups were analyzed. The treatment group included 76 patients receiving magnesium sulfate within the first hour of the initiation of rescue treatment at the hospital, and the control group included 67 patients not treated with magnesium sulphate. Among the patients in the control group, 33% (n= 22) required mechanical ventilation support, compared to only 5% (n= 4) of the patients in the treatment group (p = 0.001).
Conclusions: Intravenous infusion of magnesium sulfate during the first hour of hospitalization in patients with acute severe asthma significantly reduced the percentage of children who required mechanical ventilation support.
Craig SS, Dalziel SR, Powell CV, Graudins A, Babl FE, Lunny C. Craig SS, et al. Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD012977. doi: 10.1002/14651858.CD012977.pub2. Cochrane Database Syst Rev. 2020. PMID: 32767571 Free PMC article.
Liu X, Yu T, Rower JE, Campbell SC, Sherwin CM, Johnson MD. Liu X, et al. Pediatr Pulmonol. 2016 Dec;51(12):1414-1421. doi: 10.1002/ppul.23482. Epub 2016 May 24. Pediatr Pulmonol. 2016. PMID: 27218606 Review.
Shedd GC, Noe SM. Shedd GC, et al. Adv Emerg Nurs J. 2014 Jan-Mar;36(1):3-8. doi: 10.1097/TME.0000000000000009. Adv Emerg Nurs J. 2014. PMID: 24487258
Powell CV, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson PR; MAGNETIC study group. Powell CV, et al. Health Technol Assess. 2013 Oct;17(45):v-vi, 1-216. doi: 10.3310/hta17450. Health Technol Assess. 2013. PMID: 24144222 Free PMC article. Clinical Trial.
Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA, Rowe BH. Powell C, et al. Cochrane Database Syst Rev. 2012 Dec 12;12:CD003898. doi: 10.1002/14651858.CD003898.pub5. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898. doi: 10.1002/14651858.CD003898.pub6. PMID: 23235599 Updated. Review.
Johnson MD, Barney BJ, Rower JE, Finkelstein Y, Zorc JJ. Johnson MD, et al. JMIR Res Protoc. 2023 Jul 17;12:e48302. doi: 10.2196/48302. JMIR Res Protoc. 2023. PMID: 37459153 Free PMC article.
Toledano JM, Puche-Juarez M, Moreno-Fernandez J, Ochoa JJ, Diaz-Castro J. Toledano JM, et al. Antioxidants (Basel). 2023 May 16;12(5):1104. doi: 10.3390/antiox12051104. Antioxidants (Basel). 2023. PMID: 37237970 Free PMC article. Review.
Erumbala G, Anzar S, Tonbari A, Salem R, Powell C. Erumbala G, et al. Breathe (Sheff). 2021 Dec;17(4):210113. doi: 10.1183/20734735.0113-2021. Breathe (Sheff). 2021. PMID: 35035570 Free PMC article. Review.
Cheng T, Farah J, Aldridge N, Tamir S, Donofrio-Odmann JJ. Cheng T, et al. J Am Coll Emerg Physicians Open. 2020 Jun 8;1(5):955-964. doi: 10.1002/emp2.12103. eCollection 2020 Oct. J Am Coll Emerg Physicians Open. 2020. PMID: 33145546 Free PMC article.
Tang CF, Ding H, Jiao RQ, Wu XX, Kong LD. Tang CF, et al. Eur J Pharmacol. 2020 Nov 5;886:173546. doi: 10.1016/j.ejphar.2020.173546. Epub 2020 Sep 12. Eur J Pharmacol. 2020. PMID: 32931782 Free PMC article. Review.